Pure Global AI
MCA MCA-F-501

MCA-F-501/08, Version 3 – 24 January 2025

Clinical Trial Amendment Form
GambiaMedicines Control Agency, The GambiaClinical TrialsCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

What this code is

MCA-F-501/08, Version 3 – 24 January 2025 is the official MCA identifier for “Clinical Trial Amendment Form”. MCA-F-501/08, Version 3 – 24 January 2025 is the official identifier MCA uses for this instrument.

Instrument
MCA-F-501
Full name
MCA-F-501/08, Version 3 – 24 January 2025
Category
Clinical Trials
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Clinical Trial Amendment Form

Complete two-page clinical trial amendment form, version 3 dated 24 January 2025. It identifies the protocol and trial, related document revisions and a five-column table for current text, proposed changes, summaries and justifications. Its amendment process concerns clinical trials, including the common medical-device trial context, and is not a general device marketing modification route. Later revisions and current applicability remain unverified.

MCA-F-501/08, Version 3 – 24 January 2025 is the official identifier MCA uses for this instrument. Always confirm the current consolidated text and transition provisions with the official source before filing.